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Abstract. A miniature fiber optic spectrometer enclosed within a
semipermeable dialysis membrane is proposed for in vivo interstitial
sensing applications. The semipermeable membrane acts as a mo-
lecular filter, allowing only small molecules to pass through to the
sampling volume. This filtering, in principle, should enable continu-
ous in vivo drug sensing, removing the necessity for complex microdi-
alysis systems. We use a biological phantom to examine the reliable
detection of a fluorescence signal from small dye molecules in the
presence of large fluorophores and scatterers. We find that spectral
artefacts arising from scatterers and large fluorophores are substan-
tially suppressed, simplifying the spectral analysis. In addition, the
measured sampling rate of 157 s is superior to existing in vivo tissue
assaying techniques such as microdialysis, which can take tens of
minutes.
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1.1 In Vivo Fiber Optic Spectroscopy
Since the 1960s there has been interest in using optical fibers
for biomedical sensing.1 Optical fibers are small and flexible
and can be easily inserted into thin catheters or hypodermic
needles. They are typically made of glass or plastic, which are
nontoxic, chemically inert, and immune to electromagnetic
interference and crosstalk.2 Such properties can, in principle,
offer reliable, minimally invasive in vivo monitoring without
harmful effects to patients.
In sensing applications, optical fibers are typically used to
deliver and collect light from a probe, which interacts with a
remote sampling region. This probe can simply be a cleaved
fiber tip, or it may be a more complex optical component.3
Light sent to the sample via the probe has a unique signature
imprinted onto its spectral profile due to light-tissue interac-
tions. This signature bears information about the tissue con-
tent. The major light-tissue interaction modes are absorption
and scattering. If fluorophores are present, then light absorp-
tion is followed by the production of longer wavelength ra-
diation via fluorescence. Light-tissue interactions via elastic
scattering randomize the propagation direction of light after
each scattering event. The cumulative effect of these light-
tissue interactions can be very complex. This is due to the
abundant presence of tissue scattering constituents, such as
endogenous fluorophores, pigments, and cells.
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signal is to introduce a selective element into the fiber probe
tip. For example, during the 1980 to 1990s fiber probes incor-
porated what is known as an optrode4–8 “optical electrode”.
In the optrode approach, the optical fiber guides light to and
from a special chemical reagent. The reagent’s absorption,
fluorescence, or lifetime is affected by the concentration of a
specific target chemical, which is detected in the return signal.
This gives the fiber probe a very selective response related to
a single chemical species. The reagent must be immobilized
and kept at the tip of the fiber probe. One method is to im-
pregnate the reagent into a polymer or membrane and attach it
to the tip of the fiber.4,8 In the second method, the reagent is
trapped inside a sampling volume at the tip of the fiber probe
using a membrane.5,6 The selected membrane is permeable to
the chemical of interest, but it prevents escape of the reagent.
An issue with optrode chemical sensors is that they rely on
chemical reactions to modulate the detected optical sensor
signal. The chemical reagent stability is typically limited, thus
shortening the useful working life of optrode fiber sensor. The
response time of optrode sensors can be rapid in the case of
impregnated membranes. However, optrodes are very selec-
tive and produce a response for only a specific chemical. If
multichemical detection is required, then multiple reagents
and wavelength multiplexing systems are required.4 This in-
creases system complexity, decreases reliability, and limits the
possible applications of the designed fiber probe.
Many of these optrode systems have been used to measure
pH, O2, and CO2 concentrations in arteries and veins.4,5,7,81083-3668/2006/111/014033/7/$22.00 © 2006 SPIE
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physiological effects due to mobile dye molecules.6 However,
in commercially available systems, consistency and reliability
were unacceptable.9 This was due to significant malfunctions
and inconsistencies that were attributable to the intra-arterial
environment.9
Another method of processing in vivo spectroscopic infor-
mation is to use sophisticated numerical methods, such as
photon diffusion models. Several “success stories” of fiber
optic spectroscopy include noninvasive measurement of bi-
lirubin in neonates,10 and in vivo monitoring of blood
oxygenation.11 For these models to work, a number of param-
eters characterizing living tissue must be known accurately.
As such, this approach is susceptible to minute variations in
tissue condition and is generally prone to measurement arti-
facts. One can see that both the optrode and photon diffusion
techniques are less than adequate, if a general type of fiber
probe is required.
1.2 Drug Monitoring and Microdialysis
It is known that a common site of drug action in the body is
within its tissues. The ability to better monitor and understand
drug distribution inside various tissues can lead to improved
dosing strategies for a number of patient groups.12,13 The de-
velopment of new research tools for analyzing in vivo drug
concentrations in body tissues represents an important re-
search goal. Methods that enable continuous monitoring of
drug levels can give information about drug penetration,
transport, distribution, and pharmacokinetics inside body tis-
sues. Continuous in vivo drug monitoring is especially useful
when drugs with a narrow therapeutic index are used, or
where imprecise dosing can lead to substandard outcomes for
patients.
Currently, typically only the blood concentration of drugs
has been readily available in most human studies. There are
limited instrumental options available for measuring drug
concentration in other tissues, such as muscle, fat, and dermis.
The use of biopsies to obtain tissue concentrations is not only
painful, invasive, and time consuming but usually provides
information only at a single discrete point in time.
In the 1980s a new minimally invasive technique for con-
tinuous drug in vivo monitoring was developed called
microdialysis.14–17 In microdialysis a semipermeable dialysis
membrane tube is inserted into tissue and perfused with a
buffer solution. Drug molecules from the intercellular tissue
region diffuse across the membrane into the buffer solution.
This buffer solution and drug molecules are pumped out of
the tube, collected, and analyzed. The microdialysis technique
has been widely used, but there are several fundamental prob-
lems. Drug concentration in the buffer solution does not gen-
erally reflect drug concentration in the tissue.18 Second, the
establishment of dynamic equilibrium is a lengthy process,
due to continuous renewal of the buffer solution in the head,
which flows into a fraction collector. The sampling rate is
slow, with the first reading being tens of minutes after probe
insertion. The permeated drugs are thinly spread between the
catheters and fraction collector, compromising the readout
rate, and/or the sensitivity of the microdialysis technique.
Also, the necessary use of a catheter and a fraction collector
makes further miniaturization of microdialysis devices prob-
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solved if measurements were taken locally, inside the sam-
pling head.
2 Dialysis-Assisted Fiber Optic Spectroscopy
The combination of a fiber optic sensor and a semipermeable
membrane has been addressed for specific biomedical
applications.4–8,19,20 However, the reported approaches rather
underscore the true potential it might confer, that is, detection
of exogenous molecules, such as drugs, and also, small mol-
ecules of endogenous origin inside body tissue.
We propose to combine fiber optic spectroscopy and mi-
crodialysis into a technique called dialysis-assisted fiber optic
spectroscopy DAFOS. The key feature of the DAFOS sys-
tem is the sampling head probe, which has a fiber optic probe
enclosed in a hydrophilic dialysis membrane see Fig. 1. The
membrane surrounding the sampling head enables molecules
of small molecular weight to diffuse through the membrane
while blocking larger sized molecules. However, unlike in
microdialysis, we now optically monitor the contents of the
sampling volume locally via a fiber optic probe. The ultimate
goal of DAFOS is to monitor drug concentrations locally in
tissue. For such applications it is fortunate that most drugs
have a small molecular weight, and low affinity to proteins,
enabling their permeation into the sample head. This should
enable sufficient isolation between the target chemicals/drugs
and the constituents of the surrounding tissue.
Unlike microdialysis, DAFOS is a stationary and miniature
system, which renders it rapid, sensitive, and a reliable spec-
troscopic chemical analyzer. A rapid response is achieved due
to the small volume of the sampling head. This enables equi-
librium with the surrounding environment within minutes, not
in tens of minutes as in microdialysis. Since equilibrium is
established through passive diffusion, the DAFOS dynamics
are simpler and more tractable compared to microdialysis.
The system tested in this paper measures fluorescence with
Fig. 1 Schematic diagram of DAFOS using a single fiber for illumina-
tion and collection.one multimode optical fiber see Fig. 1. Laser light is deliv-
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abling the excitation of fluorophores. After absorption, these
excited fluorophores then reemit light at a longer wavelength
fluorescence. This fluorescence is collected by the same op-
tical fiber and guided in the opposite direction to the excita-
tion light. The return signal is then passed through a dichroic
filter to remove any scattered laser light. This filtered return
signal is then directed to a spectrometer for analysis.
In this paper, the feasibility of using the membrane as an in
situ molecular filter for fiber optic spectroscopy is tested. We
perform modeling and experiments on the fiber probe collec-
tion efficiency to determine the minimum required sampling
volume size. Finally, modeling and experimental tests are per-
formed to see if the response time constant is competitive
with the standard microdialysis.
3 DAFOS Design Considerations
To design a suitable DAFOS probe, we must know how lo-
calized the fluorescence collection efficiency is near the fiber
probe tip. This will indicate the minimum DAFOS probe size
that can be used. Second, the response time of the probe must
be shorter than that achieved with microdialysis. The response
time is limited by perfusion through the membrane and diffu-
sion inside the sampling volume. The perfusion time through
the membrane is material dependent, but the diffusion time
depends on the buffer solution and the probe geometry. In this
section, we calculate the expected collection efficiency and
response time of a simple DAFOS system.
3.1 Fiber Collection Efficiency and DAFOS Probe
Size
The optical field emerging from the distal end of a multimode
fiber can be modeled as a Gaussian beam. For a first-order
approximation, it is sufficient to assume that in the near field,
the beam has constant radius equal to the fiber core radius
rc. This beam has a uniform irradiance across its lateral
cross section. In the far field, the output beam is modeled as a
cone of light, with uniform irradiance across its lateral cross
section. The cone angle is equal to the acceptance angle of the
optical fiber, given by a=arcsinNAf /nm, where NAf is the
fiber numerical aperture, and nm is the refractive index of the
surrounding medium. Under these simplifying assumptions,
the output irradiance of the fiber is reduced to
Iin = Pin/rc2 near fieldPin/4z2NAf2 far field, 1
where Pin is the power of the excitation light and z is the
distance from the end of the fiber tip. Knowing the irradiance
profile of the excitation beam, we can calculate the fluores-
cence power generated in a specified sampling volume by the
following equation:
Pfluo =
Vsample
anIindV , 2
where  is the quantum efficiency of the fluorophore, a is its
absorption cross section cm2, and  is the fluorophore con-
centration in cm−3. The integration of Eq. 2 is simplified
into a 1-D integration over the z axis using the conditions of
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metry of the configuration, the collected fluorescence power
Pcf is given by
Pcfz0 =
0
z0
0
 dPfluo
dz
,z
2
d dz
= Pinan
0
z0
0

,z
2
d dz , 3
where  ,z is the solid angle of fluorescence light that
reaches the fiber core within its acceptance cone,  is the
radial position away from the fiber axis, z is the axial distance
from fiber tip, and z0 is the maximum axial distance at which
the fluorescence is collected.
The functional representation of  ,z depends on the
position of the fluorophore with respect to the optical fiber tip.
We have considered three main cases, as illustrated in Fig. 2.
In case 1, fluorophores are located within one Rayleigh range
from the fiber tip near field, and within one core radius rc
from the fiber axis. In case 2, fluorophores are beyond one
Rayleigh range from the fiber tip far field, but still within
one core radius from the optical axis, i.e., 	rc. In case 3, the
fluorophores are again located in the far field, but are located
more than the core radius away from the optical axis, i.e., 

rc. We find the fluorescence collection efficiency by per-
forming the integration shown in Eq. 3 to obtain the col-
lected fluorescence power Pcfz0, and then dividing it by the
input excitation power Pin.
The dependence of fiber collection efficiency versus the
sampling volume depth z0 is shown in Fig. 3. From Fig. 3, it
is clear that under our experimental conditions fluorophores in
the close vicinity of the fiber 1–2 mm primarily contribute
to the return signal. This indicates that a membrane enclosed
Fig. 2 Three fluorescence collection geometries used in the theoreti-
cal modeling; shaded regions indicate cone of collected fluorescence
light see text for details.sampling volume of several millimeters in length is sufficient
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similar theoretical modeling with this fiber probe geometry in
the context of Raman spectroscopy.21
3.2 Response Time Constant of DAFOS
Unlike traditional microdialysis, the main operation mode of
DAFOS is stationary, there is no convective buffer flow in the
sampling head. DAFOS is governed by the following two
processes: permeation of fluorophores through the membrane
and diffusion of fluorophores outside and inside of the sam-
pling head. To estimate the expected response time, we model
the DAFOS probe as a long tube of radius r0, characterized by
the permeation constant P in centimeters per second. The
fluorophore concentration inside the probe is ct, versus time
t, and the initial concentration of fluorescent drug molecules
outside the tube is cm. Equilibrium between inner and outer
regions is established by permeation and diffusion. In the
standard diffusion theory framework, the equilibrium process
can be approximated by the following relationship:
ct =
1
teq

0
t
exp− t − /teqcm d , 4
where teq is the equilibrium time. The equilibrium time teq is
the sum of the diffusion and permeation times: teq= tdiff
+ tperm, where tdiff=r0
2 / 5.76D is the diffusion time, D is the
diffusion constant cm2/s, and tperm=2r0 / P is the perme-
ation time. Assuming that tdiff tperm, and using typical pa-
rameters of our DAFOS system, r0=0.05 cm, D=2.8
10−6 cm2/s for Rh:6G in water22 and D=3.6
10−6 cm2/s for Rh:B in water,23 the tdiff equilibration time
is calculated to be 155 and 121 s, respectively. Such a short
response time constant represents a very attractive target for
biomedical drug sensing applications. It is also smaller than
the time constants achievable with standard microdialysis, in-
dicating that DAFOS may be a feasible drug analysis tech-
Fig. 3 Theoretical fluorescence collection efficiency curves for a
single fiber probe immersed in rhodamine:6G Rh:6G, using molar
concentrations in the range 1 to 20 M. The NA and core diameter of
the fiber were 0.22 and 105 m, respectively; the refractive index of
the sampling volume was 1.34; and the quantum efficiency  was
set to unity.nique.
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To carry out a preliminary experimental study of DAFOS, a
laboratory system prototype was built. It consisted of three
main parts: a fiber-optic spectrometer, a sampling head, and
liquid biological phantoms. The miniature fiber optic spec-
trometer was configured as shown in Fig. 1. The outer clad-
ding diameter, core diameter, and numerical aperture NAf
of this fiber were 125 m, 105 m, and 0.22, respectively. A
1.2-mW laser of wavelength of 532 nm was used as the illu-
mination source. This illumination source was coupled into
the multimode fiber coupling efficiency of 69% and deliv-
ered to the sampling head. A dichroic filter wavelength cut-
off, 540 nm was used to separate the illumination radiation
from the fluorescence radiation collected by the distal end of
the fiber. The collected fluorescence radiation was coupled
into a computer-controlled scanning single-grating Czerny-
Turner spectrometer Acton Research Corporation,
SpectraPro® 275, f /3.8, wavelength resolution 1.6 nm ter-
minated by a p-i-n photoreceiver.
The sampling head comprised a sealed membrane tube
filled with water, in which the fiber distal end was immersed.
The filtering performance of the membrane is determined by
its molecular cutoff. Molecular cutoff is defined as the mo-
lecular weight measured in daltons, at which 80% of the mol-
ecules are prevented from passing through the membrane. The
selected dialysis membrane had a molecular cutoff of
20,000 Dal, which was sufficient to pass fluorophores of in-
terest fluorescent dyes, molecular weight 500 Dal, but
prevent passing micrometer-sized particles, which cause sig-
nificant scattering.
In the biological phantom, rhodamine:6G dye Rh:6G was
used to represent a drug exogenous fluorophore. The endog-
enous tissue fluorophores were mimicked by micrometer-
sized dye-doped beads PC-Red™, Fluoresbrite® polychro-
matic red microspheres, diameter 2.0 m, 5.68
109 particles/ml, emission=584 nm, which were unable to
penetrate through the membrane. The scattering tissue was
mimicked by an aqueous suspension of nonfluorescent 2- and
5-m polystyrene spheres 15% by weight. In our experi-
ments, 1 M of Rh:6G was dissolved in a water/methanol
solution of equal volume ratio. This 1-M concentration was
tested, as it is a typical in vivo drug concentration that can be
achieved via the common drug delivery pathways. The liquid
biological phantom was placed in a vial, and then the sam-
pling head was immersed into the solution. The fluorescence
signal was acquired by the spectrometer and the collected data
was transferred to a PC for display, analysis, and archiving.
The acquired spectra were processed to correct for the di-
chroic filter wavelength response, and also, to remove the
instrumental high-frequency noise by lowpass filtering. The
acquired fluorescence signals using different biological phan-
toms were then normalized for comparison.
5 Results
5.1 Effect of the Dialysis Membrane on Spectroscopic
Artefact Suppression
The spectral shape of the Rh:6G fluorescence signal was ac-
quired in a clear solution Fig. 4a, solid line to serve as a
reference signal. Then the fluorescence response was tested in
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without a membrane enclosure, shown in Fig. 4a. It was
found that the fluorescence peak appeared to be red-shifted by
7.5 nm in the presence of nonfluorescent scatterers. Next the
test was repeated using our membrane-enclosed DAFOS
probe, which resulted in efficient suppression of the spectro-
scopic artefacts due to the scatterers Fig. 4a, dotted line.
Typically, the scatterer-affected peak was observed to occur
either red-shifted in wavelength, as in Fig. 4a, or blue-
shifted, depending on the scatterer size and concentration. We
speculate that it might result from the intricate interplay of
several scattering properties of nonabsorbing scatterers versus
wavelength: scattering cross section, scattering anisotropy
factor g, and probability of multiple scattering.
Next the DAFOS response to the presence of endogenous
fluorophores was tested. This was realized by using the liquid
biological phantom containing fluorescent polystyrene
spheres PC-red. The fluorescence peaks of the exogenous and
endogenous fluorophore phantoms were separated in wave-
length by 30 nm, so that the obscuring effect was profound.
Indeed, the spectroscopic signature of the exogenous fluoro-
phores phantom Fig. 4b, solid line was completely dis-
torted in the presence of the high-concentration endogenous
fluorophore phantom PC-red, as shown in Fig. 4b dashed
line. The enclosure of the sampling head with a dialysis
membrane enabled considerable suppression of these spectro-
scopic artefacts, see Fig. 4b dotted line. This was due to
the filtering property of the dialysis membrane that prevented
micrometer-sized PC-red particles from entering the sampling
head. The residual red-shift of the filtered spectroscopic signal
in DAFOS is believed to be due to the fluorescent contribu-
tion of the endogenous fluorophore phantom PC-red situated
outside the sampling head.
5.2 Detection Depth Range and Sensitivity
To demonstrate the localized nature of the fluorescence signal,
the collected fluorescence power was measured versus the
Fig. 4 a Plot of Rh:6G fluorescence spectrum using bare fiber probe
in clear solution solid line, bare fiber probe in scattering phantom
dashed line, and DAFOS probe in scattering phantom dotted line
and b plot of Rh:6G fluorescence spectrum using bare fiber probe in
clear solution solid line, bare fiber probe in fluorescent phantom
dashed line, and DAFOS probe in fluorescent phantom dotted line.axial distance from the fiber tip. The fluorescence spectrum
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650 nm, with an integration time of 250 ms per point. Nu-
merical integration over the recorded spectrum was performed
to obtain the total collected fluorescence power. The mem-
brane was not required for this measurement, which was car-
ried out in a clear Rh:6G solution. The axial signal variation
was measured by adjusting the separation between the fiber
tip and the base of a black container filled with the Rh:6G
solution. The measurement commenced by bringing the fiber
tip into contact with the base of the container, which corre-
sponded to the signal with no fluorophores. The successive
measurements of signal power were taken by raising the fiber
probe above the container base, enabling a larger volume of
fluorophores to be sampled. The result of these measurements
is plotted in Fig. 5a, marked by asterisks.
The solid line in Fig. 5a is a theoretical fit to the experi-
mental data points using Eq. 3. This graph confirms that the
major contribution to the DAFOS fluorescence signal comes
from the volume within 1.4 mm from the tip of the optical
fiber, measured at the 90% signal fall off.
To determine the detection sensitivity of the fluorescence
DAFOS system, the detected fluorescence power was plotted
versus Rh:6G molar concentration, over the range of 10 to
100 M, as shown in Fig. 5b. As expected, this dependence
was linear, with a slope of 0.431 pW/M. Intersection of this
signal line with the fluorescence signal detection threshold
noise floor yielded a minimum detectable concentration of
340 nM.
5.3 Response Time
Since the operation rate represents an important performance
indicator of the proposed technique, we carried out measure-
ments of the equilibrium time. The peak detected fluorescence
signal in a 1-mM aqueous solution of rhodamine B Rh:B
was measured versus time using the DAFOS system, and the
result is plotted in Fig. 6. The data points were normalized to
the signal saturation value.
A theoretical curve solid line was fit to the data using Eq.
5. The estimated time constant of this exponential theoreti-
cal curve yields an equilibrium time teq=157 s. This mea-
sured time constant was found to be 36 s longer than the
theoretical value of 121 s, assuming a negligible permeation
time constant. Thus, the permeation time constant was not
negligible, but approximately 30% of the expected diffusion
time constant. To increase the DAFOS operation rate the ra-
dius of the dialysis membrane tube can be reduced. This will
decrease both the permeation and radial diffusion time con-
stants. Despite a permeation time constant of the order of
2 min, the demonstrated equilibrium time is already superior
compared to the existing tissue assaying techniques, including
microdialysis.14
6 Discussion
We demonstrated that the DAFOS technique is capable of
detecting small-molecular-weight fluorescent molecules of in-
terest in the presence of an obscuring spectral environment.
The clear suppression of contributions from endogenous fluo-
rophore and scattering agents was demonstrated. The filtering
efficiency of the DAFOS laboratory system prototype, how-
ever, has room for improvement. In the case of the endog-
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spectrum of the liquid biological phantom Rh:6G remained
slightly distorted. We observed optical leakage of the 532-nm
excitation light through the membrane during experiments. It
is possible that the spectral distortion is due to unwanted ex-
citation of the fluorophores outside the sampling head. This
external excitation results in a nonnegligible contribution to
the detected fluorescence signal. To alleviate this problem, an
optically opaque membrane could be used to confine the ex-
citation radiation inside the sampling head. The use of an
optically opaque dialysis membrane would also permit the use
of intense ultraviolet UV radiation in vivo, which otherwise
represents a mutagenic hazard.24 For a broad range of molecu-
lar species, rich and detailed spectral information is available
in the UV spectral range. It is believed that a safe technique
Fig. 5 a Fluorescence signal power versus sampling volume depth: e
Plot of the fluorescence signal power versus the fluorophore Rh:6G
dotted line.
Fig. 6 Plot of the normalized DAFOS signal versus time: experiment
* , theoretical fitting curve solid line.
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ough and comprehensive analysis of drug concentration in
tissue.
We envisage several possible approaches to improve the
DAFOS system sensitivity to fluorophore concentration. An
increase of the excitation power in combination with an opti-
cally opaque membrane in the DAFOS sampling head is the
most straightforward approach. It will increase the overall
fluorescence yield, in addition to the suppression of unwanted
external contributions. Another approach involves the trade-
off between spectrometer resolution and its throughput. By
increasing the spectrometer slit width, the optical throughput
can be increased significantly. However, this increase in opti-
cal throughput reduces the resolution of the spectrometer,
which may be detrimental to the spectral analysis of the sam-
pling volume. Typically in fiber optic spectroscopy, fiber
bundles are used to improve the fluorescence collection
efficiency.13 However, in our experimental configuration the
choice of the sampling head was constrained by the mem-
brane diameter of 0.5 mm, which precluded the use of a large
number of collection fibers. A more practical method would
be to use a fiber with a larger core diameter and NAf to
improve the collection efficiency. Using a commercially avail-
able optical fiber with a core diameter of 0.4 mm and NAf of
0.37, a factor of 6 increase in collection efficiency is ex-
pected.
7 Conclusion
A new technique called DAFOS, suitable for drug sensing in
vivo, was proposed and demonstrated. The combination of
fiber optic spectroscopy and microdialysis enables efficient
suppression of the complex background spectrum that has
ent *, theoretical fit solid line. Concentration of Rh:6G is 1 M. b
tration: experiment *, linear fitting solid line, noise floor dashed-xperim
concenplagued in vivo biomedical sensing applications. We carried
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system prototype and using liquid biological phantoms.
Strong suppression of the fluorescence artefacts due to the
presence of endogenous fluorophores and scatterers was dem-
onstrated. It was shown theoretically and experimentally that
fluorophores are detected locally. The unprecedented opera-
tion rate of the DAFOS prototype in comparison with the
traditional tissue assaying techniques was demonstrated. As a
result of this preliminary study, DAFOS was demonstrated to
have strong promise as a research and analytical tool for
rapid, reliable sensing of exogenous fluorophores in live tis-
sue. In particular, DAFOS applications for sensing of minute
transient traces of drugs in living tissue are envisaged.
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